Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 22% ± 7% | |
classical monocyte | 3 studies | 29% ± 6% | |
dendritic cell | 3 studies | 23% ± 5% | |
enterocyte | 3 studies | 22% ± 4% |
Insufficient scRNA-seq data for expression of ZBTB7B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 5564.93 | 245 / 245 | 100% | 107.69 | 501 / 502 |
esophagus | 99% | 7814.59 | 1434 / 1445 | 100% | 97.01 | 183 / 183 |
bladder | 100% | 3493.86 | 21 / 21 | 99% | 61.88 | 499 / 504 |
intestine | 99% | 7707.08 | 957 / 966 | 100% | 65.16 | 525 / 527 |
stomach | 99% | 4912.34 | 356 / 359 | 99% | 67.67 | 284 / 286 |
lung | 99% | 4390.14 | 572 / 578 | 99% | 61.28 | 1149 / 1155 |
breast | 97% | 5132.37 | 447 / 459 | 100% | 103.45 | 1115 / 1118 |
liver | 99% | 4290.04 | 224 / 226 | 98% | 55.60 | 397 / 406 |
thymus | 100% | 4673.02 | 650 / 653 | 96% | 47.95 | 578 / 605 |
adrenal gland | 100% | 5781.48 | 258 / 258 | 93% | 34.41 | 214 / 230 |
pancreas | 94% | 2827.37 | 308 / 328 | 99% | 55.99 | 176 / 178 |
kidney | 97% | 2989.71 | 86 / 89 | 96% | 35.15 | 863 / 901 |
uterus | 93% | 2362.86 | 158 / 170 | 98% | 72.79 | 450 / 459 |
skin | 91% | 13327.69 | 1653 / 1809 | 98% | 39.90 | 463 / 472 |
ovary | 83% | 1921.74 | 149 / 180 | 100% | 67.02 | 430 / 430 |
brain | 43% | 841.94 | 1125 / 2642 | 78% | 16.81 | 547 / 705 |
spleen | 100% | 5280.93 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 75.82 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 56.08 | 1 / 1 |
blood vessel | 99% | 4257.40 | 1323 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 4255.95 | 1184 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 11472.65 | 912 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 35.29 | 78 / 80 |
lymph node | 0% | 0 | 0 / 0 | 90% | 39.48 | 26 / 29 |
muscle | 88% | 3961.46 | 706 / 803 | 0% | 0 | 0 / 0 |
heart | 87% | 2496.44 | 748 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0032868 | Biological process | response to insulin |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0001865 | Biological process | NK T cell differentiation |
GO_1990845 | Biological process | adaptive thermogenesis |
GO_0043377 | Biological process | negative regulation of CD8-positive, alpha-beta T cell differentiation |
GO_0007398 | Biological process | ectoderm development |
GO_2000320 | Biological process | negative regulation of T-helper 17 cell differentiation |
GO_0090336 | Biological process | positive regulation of brown fat cell differentiation |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0046628 | Biological process | positive regulation of insulin receptor signaling pathway |
GO_0007595 | Biological process | lactation |
GO_0043372 | Biological process | positive regulation of CD4-positive, alpha-beta T cell differentiation |
GO_0051141 | Biological process | negative regulation of NK T cell proliferation |
GO_2000640 | Biological process | positive regulation of SREBP signaling pathway |
GO_0032740 | Biological process | positive regulation of interleukin-17 production |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0001217 | Molecular function | DNA-binding transcription repressor activity |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | ZBTB7B |
Protein name | Zinc finger and BTB domain-containing protein 7B (Krueppel-related zinc finger protein cKrox) (hcKrox) (T-helper-inducing POZ/Krueppel-like factor) (Zinc finger and BTB domain-containing protein 15) (Zinc finger protein 67 homolog) (Zfp-67) (Zinc finger protein 857B) (Zinc finger protein Th-POK) |
Synonyms | ZFP67 ZBTB15 ZNF857B |
Description | FUNCTION: Transcription regulator that acts as a key regulator of lineage commitment of immature T-cell precursors. Exerts distinct biological functions in the mammary epithelial cells and T cells in a tissue-specific manner. Necessary and sufficient for commitment of CD4 lineage, while its absence causes CD8 commitment. Development of immature T-cell precursors (thymocytes) to either the CD4 helper or CD8 killer T-cell lineages correlates precisely with their T-cell receptor specificity for major histocompatibility complex class II or class I molecules, respectively. Cross-antagonism between ZBTB7B and CBF complexes are determinative to CD4 versus CD8 cell fate decision. Suppresses RUNX3 expression and imposes CD4+ lineage fate by inducing the SOCS suppressors of cytokine signaling. induces, as a transcriptional activator, SOCS genes expression which represses RUNX3 expression and promotes the CD4+ lineage fate. During CD4 lineage commitment, associates with multiple sites at the CD8 locus, acting as a negative regulator of the CD8 promoter and enhancers by epigenetic silencing through the recruitment of class II histone deacetylases, such as HDAC4 and HDAC5, to these loci. Regulates the development of IL17-producing CD1d-restricted naural killer (NK) T cells. Also functions as an important metabolic regulator in the lactating mammary glands. Critical feed-forward regulator of insulin signaling in mammary gland lactation, directly regulates expression of insulin receptor substrate-1 (IRS-1) and insulin-induced Akt-mTOR-SREBP signaling (By similarity). Transcriptional repressor of the collagen COL1A1 and COL1A2 genes. May also function as a repressor of fibronectin and possibly other extracellular matrix genes . Potent driver of brown fat development, thermogenesis and cold-induced beige fat formation. Recruits the brown fat lncRNA 1 (Blnc1):HNRNPU ribonucleoprotein complex to activate thermogenic gene expression in brown and beige adipocytes (By similarity). . |
Accessions | ENST00000368426.3 [O15156-1] ENST00000535420.6 [O15156-1] O15156 ENST00000292176.2 [O15156-1] ENST00000417934.6 [O15156-2] |